Posted By
Marianne Lenton
19-Dec-2019 05:26
Found In
Egroup:
Regulatory Open Forum
\
view thread
Thank you very much for your response. However, could you kindly address the following question? Hypothetical Question: An initial report is received for a Phase III Clinical Trial. The event is a Life-Threatening SUSAR event (study product is a drug, not a medical device or combination product, ...
|